Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus‐related non‐Hodgkin lymphoma

Unlike aggressive non‐Hodgkin lymphoma (NHL), Hodgkin disease (HD) develops rarely in patients who are infected by human immunodeficiency virus (HIV), and its characteristics are not well defined. The authors analyzed the clinicopathologic and prognostic features from a consecutive series of patients with HIV‐associated HD who were observed at their institution and compared them with the features observed in a concurrent series of patients with systemic HIV‐related NHL.

[1]  A. Zaniboni,et al.  A phase II trial of promace‐cytabom in previously untreated non‐hodgkin's lymphoma of intermediate‐ or high‐grade histology , 2006, Hematological oncology.

[2]  L. Grochow,et al.  Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  M. Błasińska-Morawiec,et al.  Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institution. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  G. Lenz,et al.  Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. , 1999, Blood.

[5]  L. Staudt,et al.  Reed-Sternberg cell genome expression supports a B-cell lineage. , 1999, Blood.

[6]  K. Rajewsky,et al.  Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. , 1999, The New England journal of medicine.

[7]  L. Larocca,et al.  Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells. , 1999, Blood.

[8]  A. Aisenberg.  Problems in Hodgkin's disease management. , 1999, Blood.

[9]  S. Franceschi,et al.  Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease. , 1998, Blood.

[10]  S. Franceschi,et al.  Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. , 1998, British Journal of Cancer.

[11]  J. Goedert,et al.  Spectrum of AIDS-associated malignant disorders , 1998, The Lancet.

[12]  A. Levine,et al.  Hodgkin's disease in the setting of human immunodeficiency virus infection. , 1998, Journal of the National Cancer Institute. Monographs.

[13]  C. Gisselbrecht,et al.  EPIRUBICIN, BLEOMYCIN, VINBLASTINE AND PREDNISONE (EBVP) CHEMOTHERAPY(CT) IN COMBINATION WITH ANTIRETOVIRAL THERAPY AND PRIMARY USE OF G-CSF FOR PATIENTS (PTS) WITH HODGKIN'S DISEASE AND HIV INFECTION (HD-HIV).: 63 , 1997 .

[14]  S. Franceschi,et al.  Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Raphaël,et al.  Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors. , 1995, Leukemia & lymphoma.

[16]  V. Diehl,et al.  Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group. , 1995, Journal of Clinical Oncology.

[17]  R Fischer,et al.  Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Emili Montserrat,et al.  A predictive model for aggressive non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.

[19]  John W. Ward,et al.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[20]  T M Grogan,et al.  Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.

[21]  A. Levine.  Epidemiology, clinical characteristics, and management of AIDS-related lymphoma. , 1991, Hematology/oncology clinics of North America.

[22]  R. Cuthbert,et al.  Central nervous system involvement in haematological malignancies. , 1989, Clinical and laboratory haematology.

[23]  B. Coiffier,et al.  LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  J. Kahn,et al.  AIDS-associated non-Hodgkin's lymphoma in San Francisco. , 1989, JAMA.

[25]  P. Pelicci,et al.  Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986). , 1988, Annals of internal medicine.

[26]  A. Levine,et al.  AIDS-related malignant lymphoma: results of prospective treatment trials. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  P. Volberding,et al.  Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. , 1984, The New England journal of medicine.

[28]  T. Anderson,et al.  Hodgkin's disease with leptomeningeal involvement: Report of a case with long survival , 1984, Cancer.

[29]  John McGrath,et al.  Hodgkin’s Disease , 1933, JAMA.

[30]  R. Talamini,et al.  Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus‐related, non‐Hodgkin lymphoma , 2001, Cancer.

[31]  S. Horning,et al.  Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an update. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[32]  A. Levis,et al.  182 P - Epirubicin, bleomycin, vinblastine and prednisone (EBVP) chemotherapy (CT) in combination with antiretroviral therapy and primary use of G-CSF for patients (pts) with hodgkin's disease and HIV infection (HD-HIV) , 1996 .

[33]  E. Jaffe,et al.  The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[34]  Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States. , 1985, MMWR. Morbidity and mortality weekly report.

[35]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .